US2007190021A1PendingUtilityA1
Poly(diallylamine)-based bile acid sequestrants
Est. expiryDec 30, 2016(expired)· nominal 20-yr term from priority
A61P 43/00A61P 9/10A61K 31/795A61K 31/787A61K 47/6949B82Y 5/00C08G 61/12A61K 31/785A61P 3/06A61K 31/13A61K 31/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for removing bile acids from a patient and certain polymers of use in the method. The method comprises the step of administering to the patient a therapeutically effective amount of a polymer composition which includes a a poly(diallylamine)polymer which is substituted with hydrophobic groups. The hydrophobic groups can be a substituted or unsubstituted, straight chain or branched C 3 -C 24 -alkyl group, an aralkyl group or an aryl group.
Claims
exact text as granted — not AI-modified1 . A method for removing bile acids from a patient comprising the step of orally administering to the patient a therapeutically effective amount of a poly(diallylamine)polymer wherein more than 10% of the amino nitrogen atoms are substituted by a hydrophobic substituent.
2 . The method of claim 1 wherein the polymer is a homopolymer.
3 . The method of claim 1 wherein the polymer is a copolymer.
4 . The method of claim 1 wherein the hydrophobic substituent is a normal or branched C 2 -C 24 -alkyl group.
5 . The method of claim 1 wherein the polymer comprises a repeat unit of the general formula
wherein R 2 is hydrogen, a substituted or unsubstituted C 1 -C 24 -alkyl group, a substituted or unsubstituted arylalkyl group or a substituted or unsubstituted aryl group; R 1 is a substituted or unsubstituted C 3 -C 24 -alkyl group, a substituted or unsubstituted arylalkyl group or a substituted or unsubstituted aryl group; and X − is a pharmaceutically acceptable anion.
6 . The method of claim 5 wherein X − is a conjugate base of an acid selected from the group consisting of hydrochloric acid, hydrobromic acid, citric acid, tartaric acid, lactic acid, phosphoric acid, methanesulfonic acid, acetic acid, formic acid, maleic acid, fumaric acid, malic acid, succinic acid, malonic acid, sulfuric acid, L-glutamic acid, L-aspartic acid, pyruvic acid, mucic acid, benzoic acid, glucuronic acid, oxalic acid, ascorbic acid and acetylglycine.
7 . The method of claim 5 wherein R 1 is a normal or branched C 3 -C 24 -alkyl group which is substituted by an amino group, an ammonium group, an amido group, a hydroxyl group, a sulfone group, a sulfoxide group or an alkoxy group.
8 . The method of claim 5 wherein R 1 is an alkyl group selected from the group consisting of hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl and tetradecyl.
9 . The method of claim 8 wherein R 2 is methyl and R 1 is selected from the group consisting of octyl, decyl and dodecyl.
10 . The method of claim 1 wherein the polymer is characterized by a repeat unit of the general formula
wherein R is a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group.
11 . The method of claim 10 wherein R is a C 3 -C 24 -alkyl group.
12 . The method of claim 11 wherein the alkyl group is selected from the group consisting of hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl and tetradecyl.
13 . The method of claim 11 wherein the alkyl group is substituted by an amino group, an ammonium group, an amido group, a hydroxyl group, a sulfoxide group, a sulfone group or an alkoxy group.
14 . The method of claim 1 wherein the polymer comprises a first monomer of the general formula
wherein R 1 is hydrogen, a substituted or unsubstituted C 1 -C 24 -alkyl group or a substituted or unsubstituted aryl group; R 2 is a substituted or unsubstituted C 3 -C 24 -alkyl group or a substituted or unsubstituted aryl group; and X − is a pharmaceutically acceptable anion; and a second monomer of the general formula
wherein R is hydrogen, a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group.
15 . The method of claim 1 wherein the polymer is a crosslinked polymer.
16 . The method of claim 15 wherein the polymer is crosslinked by a multifunctional co-monomer.
17 . The method of claim 16 wherein the multifunctional co-monomer is selected from the group consisting of diacrylates, triacrylates, tetraacrylates, dimethacrylates, diacrylamides, dimethacrylamides, diallylacrylamides and polyvinylarenes.
18 . (canceled)
19 . The method of claim 16 wherein the multifunctional comonomer is a multifunctional diallylamine.
20 . (canceled)
21 . (canceled)
22 . The method of claim 15 wherein the polymer is crosslinked by a bridging unit selected from the group consisting of straight chain or branched, substituted or unsubstituted alkylene groups, diacylalkylene groups, diacylarene groups and alkylene bis(carbamoyl) groups.
23 - 55 . (canceled)Join the waitlist — get patent alerts
Track US2007190021A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.